Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report

Medical Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles